Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
Diabetic retinopathy (DR) continues to be the leading cause of preventable vision loss among working-aged adults, marked by immune dysregulation within the retinal microenvironment. Typically, the retina is considered as an immune-privileged organ, where circulating immune cells are restricted from...
Saved in:
| Main Authors: | Bowen Zhao, Yin Zhao, Xufang Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Pharmacological Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S104366182400450X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating Cell-Free DNA as an Epigenetic Biomarker for Early Diabetic Retinopathy: A Narrative Review
by: Boaz Li, et al.
Published: (2025-05-01) -
Identifying Therapeutic Targets and Potential Drugs for Diabetic Retinopathy: Focus on Oxidative Stress and Immune Infiltration
by: Peng H, et al.
Published: (2025-02-01) -
Downregulation of MerTK in circulating T cells of patients with non-proliferative diabetic retinopathy
by: Shimiao Bu, et al.
Published: (2025-01-01) -
Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan
by: Aizhan Magazova, et al.
Published: (2025-04-01) -
Histone Modifications: Potential Therapeutic Targets for Diabetic Retinopathy
by: Yao Lu, et al.
Published: (2025-04-01)